Publications by authors named "Jeff Boyle"

Claim this Profile
P
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals.
Soumya Jaganathan, Francis Stieber, Sonia N Rao, Vladyslav Nikolayevskyy, Davide Manissero, Jeff Boyle

Infect Dis Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Diagnostic Tests for Lyme Disease.
Steven E Schutzer, Barbara A Body, Jeff Boyle, Bernard M Branson, Raymond J Dattwyler

Clin Infect Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.
John A Branda, Barbara A Body, Jeff Boyle, Bernard M Branson, Raymond J Dattwyler

Clin Infect Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.
Steven M Callister, Dean A Jobe, Aleksandra Stuparic-Stancic, Misato Miyamasu, Jeff Boyle

Clin Infect Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens.
Monica Losi, Ashley J Knights, Francesca Mariani, Alfonso M Altieri, Gregorino Paone, Jeff Boyle

Eur Respir J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.
Nicholas S Wilson, Becky Yang, Adriana Baz Morelli, Sandra Koernig, Annie Yang, Jeff Boyle

Immunol Cell Biol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
Eugene Maraskovsky, Max Schnurr, Nick S Wilson, Neil C Robson, Jeff Boyle

Immunol Cell Biol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional recovery after anterior cruciate ligament reconstruction: a longitudinal perspective.
Diana M Hopper, Geoff R Strauss, Jeff J Boyle, Jonathan Bell

Arch Phys Med Rehabil· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling.
Nicholas S Wilson, Louise J Young, Fiona Kupresanin, Shalin H Naik, David Vremec, Jeff Boyle

Immunol Cell Biol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.
Debbie Drane, Charmaine Gittleson, Jeff Boyle, Eugene Maraskovsky

Expert Rev Vaccines· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.
Jeff Boyle, Donna Eastman, Christine Millar, Sarina Camuglia, John Cox

Vaccine· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene gun immunization in a preclinical model is enhanced by B7 targeting.
Mary Tachedjian, Jeff S Boyle, Andrew M Lew, Biserka Horvatic, Jean-Pierre Y Scheerlinck

Vaccine· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis